117 related articles for article (PubMed ID: 11099902)
1. The effect of deoxynucleosides on cell proliferation of peripheral blood lymphocytes treated with deferoxamine or hydroxyurea.
van der Bruggen T; Georgiou NA; Oudshoorn M; Nottet HS; Marx JJ; van Asbeck BS
Transfus Sci; 2000 Dec; 23(3):243-4. PubMed ID: 11099902
[No Abstract] [Full Text] [Related]
2. Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in culture.
Sato A; Carter GL; Bacon PE; Cory JG
Adv Enzyme Regul; 1983; 21():259-70. PubMed ID: 6400064
[TBL] [Abstract][Full Text] [Related]
3. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.
Cory JG; Lasater L; Sato A
Biochem Pharmacol; 1981 May; 30(9):979-84. PubMed ID: 6786297
[No Abstract] [Full Text] [Related]
4. Hydroxyurea promotes the reduction of spontaneous BFU-e to normal levels in SS and S/beta thalassemic patients.
Bincoletto C; Perlingeiro RC; Saad ST; Costa FF; Queiroz ML
Hemoglobin; 2001 Feb; 25(1):1-7. PubMed ID: 11300342
[TBL] [Abstract][Full Text] [Related]
5. [Effect of hydroxyurea on adhesion proteins in sickle cell anemia].
Odièvre MH; Lapouméroulie C; Elion J
Arch Pediatr; 2009 Feb; 16(2):95-8. PubMed ID: 19167870
[No Abstract] [Full Text] [Related]
6. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction.
Yang YM; Pace B; Kitchens D; Ballas SK; Shah A; Baliga BS
Am J Hematol; 1997 Dec; 56(4):252-8. PubMed ID: 9395188
[TBL] [Abstract][Full Text] [Related]
7. Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay.
Anderson D; Yardley-Jones A; Vives-Bauza C; Chua-Anusorn W; Cole C; Webb J
Teratog Carcinog Mutagen; 2000; 20(5):251-64. PubMed ID: 10992272
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers GP
Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
[No Abstract] [Full Text] [Related]
9. The inhibitory effect of deferoxamine on DNA synthesis in human lymphocytes.
Wang ST; Jin KL; Li TH
Chin Med J (Engl); 1989 Dec; 102(12):902-5. PubMed ID: 2517733
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
11. Induction synchrony in the fission yeast. Schizosaccharomyces pombe.
Mitchison JM; Creanor J
Exp Cell Res; 1971 Aug; 67(2):368-74. PubMed ID: 4255493
[No Abstract] [Full Text] [Related]
12. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in culture.
Sato A; Carter GL; Bacon PE; Cory JG
Cancer Res; 1982 Nov; 42(11):4353-7. PubMed ID: 6751522
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
Lemonne N; Charlot K; Waltz X; Ballas SK; Lamarre Y; Lee K; Hierso R; Connes C; Etienne-Julan M; Romana M; Connes P
Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
[No Abstract] [Full Text] [Related]
14. Replication status in leukocytes of treated and untreated patients with polycythemia vera and essential thrombocytosis.
Amiel A; Elis A; Maimon O; Ellis M; Herishano Y; Gaber E; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2002 Feb; 133(1):34-8. PubMed ID: 11890987
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease.
Fung EB; Barden EM; Kawchak DA; Zemel BS; Ohene-Frempong K; Stallings VA
J Pediatr Hematol Oncol; 2001 Dec; 23(9):604-8. PubMed ID: 11902305
[TBL] [Abstract][Full Text] [Related]
16. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Sato A; Bacon PE; Cory JG
Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
[TBL] [Abstract][Full Text] [Related]
17. Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin.
Kim-Shapiro DB; King SB; Bonifant CL; Kolibash CP; Ballas SK
Biochim Biophys Acta; 1998 Mar; 1380(1):64-74. PubMed ID: 9545536
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation.
Lederman HM; Cohen A; Lee JW; Freedman MH; Gelfand EW
Blood; 1984 Sep; 64(3):748-53. PubMed ID: 6380622
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by caffeine of the growth inhibitory effects of antimetabolites in lymphoma L5178Y cells.
Lowe JK; Henderson JF
Biochem Pharmacol; 1977 Aug; 26(16):1533-4. PubMed ID: 302705
[No Abstract] [Full Text] [Related]
20. Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents.
Cory AH; He AW; Cory JG
Adv Enzyme Regul; 1998; 38():3-18. PubMed ID: 9762343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
